CBD vs CBN for Sleep

CBD (cannabidiol) is the compound hemp is best known for, and the plant makes it directly. CBN (cannabinol) is different. A 2021 review in Cannabis and Cannabinoid Research calls CBN "a degradative product" of THC that increases "as THC is exposed to light, oxygen, and heat." Fresh hemp holds very little, so the CBN in a gummy is usually an isolate that was made, not harvested.

Is CBN intoxicating? The same review cites older studies finding CBN "is capable of producing a marihuana-like 'high' although the doses necessary for it are several orders of magnitude larger than those of delta-9-THC." In the 2026 CUPID trial, a single 300mg dose produced mild subjective drug effects and did not impair next-morning lane-keeping in a driving simulator, though speed control changed subtly under divided attention. At sleep-product amounts CBN is treated as non-intoxicating. Still, don't drive after any sleep product until you know how it affects you.

CBD first. A 2023 systematic review found 34 studies reporting better insomnia symptoms in at least some participants, but 21 tested CBD with equal parts THC, only two focused on people with insomnia, and most had no objective sleep measure. A 2019 chart review of 72 psychiatric patients, nearly all on 25mg of CBD a day, saw sleep scores improve in two thirds the first month, then fluctuate, with no placebo group. NCCIH's summary of cannabinoid sleep studies: it's uncertain whether the products helped sleep directly or people slept better because other symptoms eased.

CBN's story is shorter and newer. The 2021 review found no trials with validated sleep measures. Since then, a 2024 trial run and funded by Canopy Growth gave 293 self-described poor sleepers 20mg nightly for a week: its primary sleep quality endpoint missed significance, awakenings and overall sleep disturbance improved versus placebo, and time to fall asleep didn't change. A 2024 trial of 1,020 adults who wanted better sleep, funded by CBN maker Floraworks, found four weeks of 25mg to 100mg improved self-reported sleep about as much as 4mg melatonin. The 2026 CUPID trial (20 adults with diagnosed insomnia, one night per dose) found no significant change in its primary outcome, wake after sleep onset, though 300mg cut time to fall asleep by about seven minutes and improved rated sleep quality. Promising, short, far from proven.

A 2020 study spiked clean urine with CBD, CBN, CBC and CBG and ran two common THC immunoassays. Both cross-reacted with CBN: one needed about five times as much CBN as THC metabolite to reach its cutoff signal, the other about 20 times, and CBN added to the signal from real THC metabolite. The authors suggest confirmatory testing when a screen doesn't match expectations.

CBD's risk is different in kind: the small amount of THC full spectrum products legally contain, up to 0.3% total THC by dry weight under the federal hemp definition. If you're tested for work, a broad spectrum or isolate CBD product without CBN is the lower-risk choice, and anything with CBN deserves a conversation with your testing program first.

Federal law defines hemp as Cannabis sativa and "all derivatives, extracts, cannabinoids, isomers, acids, salts, and salts of isomers" with total THC of not more than 0.3% on a dry weight basis. That language is from Public Law 119-37, signed November 12, 2025, which also caps finished hemp cannabinoid products at 0.4 milligrams of total THC per container. H.R. 6500, signed September 2, 2026, moved that standard and cap to December 11, 2026. CBD and CBN from compliant hemp share that definition, and the per-container cap reaches any full spectrum product with trace THC, so neither is simply legal everywhere.

The law does not name CBN. It lets Health and Human Services treat cannabinoids with THC-like effects as THC for the cap, and that list is unpublished, so we won't speculate on where CBN lands. State rules vary, so check your state before ordering. Hemp CBD and CBN products are not FDA-evaluated; the only FDA-approved CBD drug is Epidiolex, for rare seizure disorders.

CBD has the longer safety file because of Epidiolex. The FDA lists drowsiness among CBD's side effects, warns it may change how other medications work, says CBD can cause liver injury, and notes that CBD with alcohol or other sedating drugs raises the risk of sedation. The liver signal came at prescription doses, far above a typical gummy, but it's why anyone on medication should ask a doctor or pharmacist first.

People also ask whether CBN is hard on the liver. We couldn't find a human study that answers it, which is the answer: CBN's safety data is thin. In the trials we read, side effects were mild to moderate and 20mg nightly didn't change daytime fatigue versus placebo. None of it is long-term data. If you're pregnant, nursing, drinking, or on medication, ask a professional first.

The research doesn't support leaning on either cannabinoid alone. Our Partnered Reserve Sleep Gummies pair full spectrum CBD distillate (750mg CBD per jar) with CBN isolate (150mg per jar) and MicroActive Melatonin, a time-release form. The Sleep Tincture is the same idea in a coconut-flavored dropper: 2,000mg CBD and 300mg CBN per bottle plus melatonin, one 1ml serving up to twice a day or as a medical professional directs.

Melatonin has its own evidence and cautions. NCCIH says short-term use "appears to be safe for most people," that it may help with jet lag and delayed sleep-wake phase disorder, and that sleep medicine guidelines don't find the evidence strong enough to recommend it for chronic insomnia. Headache, dizziness, nausea and sleepiness are the reported side effects, and NCCIH cites a 2023 study that found 22 of 25 melatonin gummy products mislabeled. Our answer is the COA for every batch on our Lab Results page.